Igloo raises $8.2M to bring insurance to more people in Southeast Asia

Singapore-based Igloo, formerly known as Axinan, has raised $8.2 million as the insurance-tech startup looks to broaden its foothold in half a dozen Southeast Asian markets and Australia.

InVent, a corporate venture capital arm of telecommunications firm Intouch Holdings, led Igloo’s extended Series A round, the startup told TechCrunch. Existing investors Openspace Ventures, a venture capital fund that invests in Southeast Asia, and Linear Capital, a Shanghai-based early-stage venture capital firm focusing on tech-driven startups, participated in this round, which makes four-year-old Igloo’s to-date raise to $16 million. It raised about $1 million in its Seed financing round.

Igloo — founded by Wei Zhu, who previously served as Chief Technology Officer at Grab — works with e-commerce and travel firms such as Lazada, RedDoorz, and Shopee in Southeast Asia to offer their customers insurance products that provide protection on electronics, and coverage on accidents and travel.

The startup, which also operates in Vietnam, Philippines, Thailand, Singapore, Indonesia, and Malaysia, said more than 15 million users have benefitted from its insurance products to date, and in the last one year it has processed more than 50 million transactions.

Igloo, which rebranded from Axinan this month, said insurance products are proving especially useful to — and popular among — people during the coronavirus outbreak.

Raunak Mehta, Chief Commercial Officer at Igloo, told TechCrunch that the startup has seen a surge in transactions and customer acquisitions in the last 45 days. “While some travel related business have seen a dip, the larger e-commerce business continues to see a surge,” he added.

“With COVID-19 impacting every facet of personal life and business, digitisation can help the world adjust to the new normal. This is especially apparent in insurance, where we can tap on digital channels for distribution and also for creating awareness,” said Zhu.

“We see that digital insurance is on the rise in Southeast Asia, and we believe that Igloo, with our digital-first approach and expansion of our product portfolio into personal health, accident and other related products can help fill those gaps and address consumers’ needs for personal well-being,” he added.

He said the digital insurance penetration remains low in Southeast Asia, and Igloo sees massive opportunity in the space. According to one estimate (PDF), Southeast Asia’s digital insurance market is currently valued at $2 billion and is expected to grow to $8 billion by 2025.

The startup, which competes with a handful of startups including Singapore Life and Saphron, will use the fresh capital to expand its business development and engineering teams and broaden its presence in the half-dozen markets. It is already engaging with telecom operators, banks, non-banking financial firms, and travel agencies, it said.

Filipino live streaming app Kumu raises $5 million Series A led by Openspace Ventures

Kumu Holdings, a live streaming startup based in the Philippines, announced today it has raised about $5 million in Series A funding, earmarked for new features and growing its operations.

The round was led by Openspace Ventures, an early investor in Go-Jek, with participation from Kickstart Ventures, media conglomerate ABS-CBN, Gobi-Core Philippine Fund, and returning investors Summit Media and Foxmont Capital Partners.

With much of the country under COVID-19 lockdown or curfew orders, Kumu says usage of media and entertainment apps has increased. To address demand, the startup has launched new features over the past month to allow organizations like churches and industry groups to hold online events.

Kumu says it now has three million registered users and about 25,000 live streams broadcast each day, with average daily usage of about one hour.

Founded two years ago by Roland Ros and Rexy Josh Dorado, Kumu aspires to be a “super app” for Filipinos around the world, integrating live streaming, video chats and gaming, with plans to add online payments and e-commerce functions, too. Kumu’s upcoming features include a live commerce platform that allows users to buy items during live streams, giving content creators an additional source of revenue.

UK researchers develop new low-cost, rapid COVID-19 test that could even be used at home

A new type of test developed by UK researchers from the Brunel University London, Lancaster University and the University of Surrey can provide COVID-19 detection in as little as 30 minutes, using hand-held hardware that costs as little as £100 (around $120 USD) with individual swab sample kits that cost around $5 per person. The test is based on existing technology that has been used in the Philippines for testing viral spread in chickens, but it’s been adapted by researchers for use with COVID-19 in humans, and the team is now working on ramping mass production.

This test would obviously need approval by local health regulatory bodies like the FDA before it goes into active use in any specific geography, but the researchers behind the project are “confident it will respond well,” and say they could even make it available for use “within a few weeks.” The hardware itself is battery-operated and connects to a smartphone application to display diagnostic results and works with nasal or throat swabs, without requiring that samples be round-tripped to a lab.

There are other tests already approved for use that use similar methods for on-site testing, including kits and machines from Cepheid and Mesa Biotech. These require expensive dedicated table-top micro-labs, however, which is installed in dedicated healthcare facilities including hospitals. This test from UK scientists has the advantage of running on inexpensive hardware, with testing capabilities for up to six people at once, which can be deployed in doctor’s offices, hospitals and even potentially workplaces and homes for truly widespread, accessible testing.

Some frontline, rapid results tests are already in use in the EU and China, but these are generally serological tests that rely on the presence of antibodies, whereas this group’s diagnostics are molecular, so it can detect the presence of viral DNA even before antibodies are present. This equipment could even potentially be used to detect the virus in asymptomatic individuals who are self-isolating at home, the group notes, which would go a long way to scoping out the portion of the population that’s not currently a priority for other testing methods, but that could provide valuable insight into the true extend of silent, community-based transmission of the coronavirus.